Search

Your search keyword '"Suzuki, Tomotaka"' showing total 313 results

Search Constraints

Start Over You searched for: Author "Suzuki, Tomotaka" Remove constraint Author: "Suzuki, Tomotaka"
313 results on '"Suzuki, Tomotaka"'

Search Results

4. Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution

6. A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma

9. Holographic Duality for 3D Spin-3 Gravity Coupled to Scalar Field

11. A Bulk Localized State and New Holographic Renormalization Group Flow in 3D Spin-3 Gravity

12. Inkjet printing-based volumetric display projecting multiple full-colour 2D patterns

13. Study of the AdS$_2$/CFT$_1$ Correspondence with the Contribution from the Weyl Anomaly

20. P820: POTENTIAL IMMUNOSUPPRESSIVE EFFECT OF EXTRACELLULAR VESICLES FROM PATIENTS WITH MULTIPLE MYELOMA

22. Low‐dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.

23. CIT Brains KidSize Robot: RoboCup 2015 KidSize League Winner

24. Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia

28. Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features

33. Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients

34. Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105

35. Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients.

36. Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.

45. CIT Brains KidSize Robot: RoboCup 2015 KidSize League Winner

47. P-126: The prognostic impact of the UK Myeloma Research Alliance Risk Profile in untreated patients with multiple myeloma who received melphalan, prednisolone, and bortezomib: an ad hoc analysis of JCOG1105

Catalog

Books, media, physical & digital resources